Prospective Non-interventional Study of Clinical Outcomes and Biomarkers in Patients With Stage 0-IV Melanoma in Real Clinical Practice
Conditions:   Melanoma;   Melanoma (Skin);   Melanoma, Uveal;   Melanoma Stage IV;   Melanoma Stage III;   Melanoma, Stage II;   Melanoma in Situ;   Melanoma, Ocular Intervention:   Drug: surgery (any volume) and / or pharmaceuticals treatment initiated or planned or only dynamic observation, in accordance with current clinical guidelines Sponsor:   MelanomaPRO, Russia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 2, 2022 Category: Research Source Type: clinical trials

Tebentafusp in Molecular Relapsed Disease (MRD) Melanoma
Conditions:   Melanoma (Skin);   Melanoma, Uveal Intervention:   Drug: Tebentafusp Sponsors:   University of Oxford;   Immunocore Ltd;   Natera, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 7, 2022 Category: Research Source Type: clinical trials